FDA Inspection 871443 — Hubei Biocause Heilen Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Biocause Heilen Pharmaceutical Co., Ltd. on November 22, 2013 in Jingmen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 22, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jingmen (China)